|
1
|
Cheng L, Yu H, Yan N, Lai K and Xiang M:
Hypoxia-inducible factor-1α target genes contribute to retinal
neuroprotection. Front Cell Neurosci. 11:202017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaur C, Foulds WS and Ling EA:
Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol.
2:879–889. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim SY, Choi YJ, Joung SM, Lee BH, Jung YS
and Lee JY: Hypoxic stress up-regulates the expression of Toll-like
receptor 4 in macrophages via hypoxia-inducible factor. Immunology.
129:516–524. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dvoriantchikova G, Barakat DJ, Hernandez
E, Shestopalov VI and Ivanov D: Toll-like receptor 4 contributes to
retinal ischemia/reperfusion injury. Mol Vis. 16:1907–1912.
2010.PubMed/NCBI
|
|
6
|
Liu L, Jiang Y and Steinle JJ: Toll-like
receptor 4 reduces occludin and zonula occludens 1 to increase
retinal permeability both in vitro and in vivo. J Vasc Res.
54:367–375. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tolkatchev D, Malik S, Vinogradova A, Wang
P, Chen Z, Xu P, Bennett HP, Bateman A and Ni F: Structure
dissection of human progranulin identifies well-folded
granulin/epithelin modules with unique functional activities.
Protein Sci. 17:711–724. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petkau TL and Leavitt BR: Progranulin in
neurodegenerative disease. Trends Neurosci. 37:388–398. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abella V, Scotece M, Conde J, López V,
Pirozzi C, Pino J, Gómez R, Lago F, González-Gay MÁ and Gualillo O:
The novel adipokine progranulin counteracts IL-1 and TLR4-driven
inflammatory response in human and murine chondrocytes via TNFR1.
Sci Rep. 6:203562016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Drummond GB, Paterson DJ and McGrath JC:
ARRIVE: New guidelines for reporting animal research. J Physiol.
588:25172010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schröder S, Palinski W and
Schmid-Schönbein GW: Activated monocytes and granulocytes,
capillary nonperfusion, and neovascularization in diabetic
retinopathy. Am J Pathol. 139:81–100. 1991.PubMed/NCBI
|
|
12
|
Sha T, Sunamoto M, Kitazaki T, Sato J, Ii
M and Iizawa Y: Therapeutic effects of TAK-242, a novel selective
Toll-like receptor 4 signal transduction inhibitor, in mouse
endotoxin shock model. Eur J Pharmacol. 571:231–239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jian J, Li G, Hettinghouse A and Liu C:
Progranulin: A key player in autoimmune diseases. Cytokine.
101:48–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rosen EY, Wexler EM, Versano R, Coppola G,
Gao F, Winden KD, Oldham MC, Martens LH, Zhou P, Farese RV Jr and
Geschwind DH: Functional genomic analyses identify pathways
dysregulated by progranulin deficiency, implicating Wnt signaling.
Neuron. 71:1030–1042. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kumar-Singh S: Progranulin and TDP-43:
Mechanistic links and future directions. J Mol Neurosci.
45:561–573. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jian J, Zhao S, Tian Q, Gonzalez-Gugel E,
Mundra JJ, Uddin SM, Liu B, Richbourgh B, Brunetti R and Liu CJ:
Progranulin directly binds to the CRD2 and CRD3 of TNFR
extracellular domains. FEBS Lett. 587:3428–3436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ,
Liu GY, Syed NM, Lai Y, Lin EA, Kong L, et al: The growth factor
progranulin binds to TNF receptors and is therapeutic against
inflammatory arthritis in mice. Science. 332:478–484. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsuruma K, Yamauchi M, Sugitani S, Otsuka
T, Ohno Y, Nagahara Y, Ikegame Y, Shimazawa M, Yoshimura S, Iwama T
and Hara H: Progranulin, a major secreted protein of mouse
adipose-derived stem cells, inhibits light-induced retinal
degeneration. Stem Cells Transl Med. 3:42–53. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Enoki M, Shinto S, Matsuoka Y, Otsuka A,
Kaidzu S, Tanito M, Shibata T, Uchida K, Ohira A, Yamato M and
Yamada KI: Lipid radicals cause light-induced retinal degeneration.
Chem Commun (Camb). 53:10922–10925. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arden GB and Sivaprasad S: Hypoxia and
oxidative stress in the causation of diabetic retinopathy. Curr
Diabetes Rev. 7:291–304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stephen J Ryan: Retina. 1. 4th. Elsevier;
Singapore: 2010
|
|
22
|
Niwa M, Aoki H, Hirata A, Tomita H, Green
PG and Hara A: Retinal cell degeneration in animal models. Int J
Mol Sci. 17:E1102016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hara A, Niwa M, Aoki H, Kumada M, Kunisada
T, Oyama T, Yamamoto T, Kozawa O and Mori H: A new model of retinal
photoreceptor cell degeneration induced by a chemical
hypoxia-mimicking agent, cobalt chloride. Brain Res. 1109:192–200.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abcouwer SF and Gardner TW: Diabetic
retinopathy: Loss of neuroretinal adaptation to the diabetic
metabolic environment. Ann NY Acad Sci. 1311:174–190. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gaillard F, Kuny S and Sauvé Y:
Topographic arrangement of S-cone photoreceptors in the retina of
the diurnal Nile grass rat (Arvicanthis niloticus). Invest
Ophthalmol Vis Sci. 50:5426–5434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aiello LP, Avery RL, Arrigg PG, Keyt BA,
Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et
al: Vascular endothelial growth factor in ocular fluid of patients
with diabetic retinopathy and other retinal disorders. N Engl J
Med. 331:1480–1487. 1994. View Article : Google Scholar : PubMed/NCBI
|
